BrainStorm Cell Therapeutics to Announce Second Quarter Results and Provide a Corporate Update
NEW YORK, Aug. 7, 2024 /PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell therapeutics...
PR News
Pharmacosmos Group to Acquire G1 Therapeutics
- Business Combination Expected to Provide Patients with Extensive Stage Small Cell Lung Cancer (ES-SCLC) Optimal Access to G1’s COSELA®...
Emerson Reports Third Quarter 2024 Results; Updates 2024 Outlook
ST. LOUIS, Aug. 7, 2024 /PRNewswire/ -- Emerson (NYSE: EMR) today reported results1 for its third quarter ended June 30, 2024 and...
Anavex Life Sciences Reports Fiscal 2024 Third Quarter Financial Results and Provides Business Update
Company to host a webcast today at 8:30 a.m. Eastern TimeRead more at globenewswire.com
Alzamend Neuro Partners with Massachusetts General Hospital for a Phase II Clinical Trial of AL001, a Next‑Generation Lithium Therapeutic Drug Candidate, involving Patients with Bipolar Disorder
Harvard University Associate Professor, Dr. Ovidiu Andronesi MD, PhD, will be the principal investigator of the study Head-to-head study of...
Alimera Sciences Reports Second Quarter 2024 Results
ATLANTA, Aug. 06, 2024 (GLOBE NEWSWIRE) -- Alimera Sciences, Inc. (Nasdaq: ALIM) (“Alimera”), a global pharmaceutical company whose mission is...
Advantage Solutions Receives Amazon’s Inaugural Gold Tier Award, Reflecting Excellence in Omnicommerce Performance
ST. LOUIS, Aug. 06, 2024 (GLOBE NEWSWIRE) -- Advantage Solutions Inc. (NASDAQ: ADV), a leading provider of sales and marketing...
ACM Research Reports Second Quarter 2024 Results
FREMONT, Calif., Aug. 07, 2024 (GLOBE NEWSWIRE) -- ACM Research, Inc. (“ACM”) (NASDAQ: ACMR), a leading supplier of wafer processing...
VSee Health and Stand Together Partner to Launch Aimee Telehealth Service
Contacts LHA Investor Relations Tirth T. Patel 212-201-6614 tpatel@lhai.com VSee Health, Inc. (Nasdaq: VSEE), a provider of comprehensive telehealth services...
Sangamo Therapeutics Reports Recent Business Highlights and Second Quarter 2024 Financial Results
Announced global epigenetic regulation and capsid delivery license agreement with Genentech to develop novel genomic medicines for neurodegenerative diseases. Expect...
Core Scientific Announces Exercise of Additional Contract Option by CoreWeave for Delivery of Approximately 112 MW of Additional Infrastructure to Host High-Performance Computing Operations
Expands Total Contracted HPC Infrastructure by CoreWeave to 382 Megawatts at Five Core Scientific sites Increases Potential Cumulative Revenue to...
Bioventus Reports Second Quarter Financial Results
DURHAM, N.C., Aug. 06, 2024 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) ("Bioventus" or the "Company"), a global leader in...
National CineMedia, Inc. Reports Results for Fiscal Second Quarter 2024
Revenue of $54.7 million exceeds guidance Advertising revenue per attendee reaches $0.56, surpassing 2019 levels National advertising revenue per attendee...
Banzai Welcomes 1,255 Customers in 2024, Demonstrating Robust Adoption and Customer Loyalty
SEATTLE, Aug. 06, 2024 (GLOBE NEWSWIRE) -- Banzai International, Inc. (NASDAQ: BNZI) (“Banzai” or the “Company”), a leading marketing technology...
Mullen CEO Provides Company Update
Company total assets are expected to be approximately $191.4 million as of June 30, 2024, and will be reported in...
Expion360 Partners with K-Z Recreational Vehicles, a Division of Thor Industries, Inc., to Provide Advanced Lithium Battery Solutions
REDMOND, Ore., Aug. 06, 2024 (GLOBE NEWSWIRE) -- Expion360 Inc. (Nasdaq: XPON) (“Expion360” or the “Company”), an industry leader in...
Sangamo Therapeutics Announces Global Epigenetic Regulation and Capsid Delivery License Agreement with Genentech to Develop Novel Genomic Medicines for Neurodegenerative Diseases
Agreement leverages Sangamo’s proprietary capsid delivery platform and epigenetic regulation capabilities to address certain neurodegenerative diseases Sangamo expected to receive...
Exagen Inc. Reports Strong Second Quarter 2024 Results: Raises Guidance due to Record Performance
CARLSBAD, Calif., Aug. 05, 2024 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today...
TeraWulf Announces July 2024 Production and Operations Update
Advancements of AI/HPC digital infrastructure projects at Lake Mariner10 EH/s of installed and operational self-mining capacity, up 100.0% Y-o-Y Read...
Workhorse Group Sets Second Quarter 2024 Earnings Call for Wednesday, August 14, 2024 at 10:00 a.m. ET
CINCINNATI, Aug. 05, 2024 (GLOBE NEWSWIRE) -- Workhorse Group Inc. (Nasdaq: WKHS) (“Workhorse” or “the Company”), an American technology company...
WISeKey Renews WebTrust Compliance for OISTE/WISeKey Global Root of Trust
Geneva and Zug, Switzerland – August 6, 2024 – WISeKey International Holding Ltd (“WISeKey”, SIX: WIHN; Nasdaq: WKEY), a leading...
Viatris Announces Second Quarter 2024 Dividend
PITTSBURGH, Aug. 6, 2024 /PRNewswire/ -- Viatris Inc. (NASDAQ: VTRS) today announced that on August 5, 2024, its Board of...
ViaSat-3 F1 Satellite Enters Commercial Service
New Viasat Capacity to Enhance Passenger Wi-Fi Services for Airlines Operating Over North America, Including Routes to Hawaii CARLSBAD, Calif.,...
UroGen Pharma to Report Second Quarter 2024 Financial Results on Tuesday, August 13, 2024
Conference Call and Webcast Scheduled for Tuesday, August 13, 2024, at 10:00 AM ET Contacts INVESTOR CONTACT: Vincent Perrone Senior...
Twist Bioscience and bitBiome Announce Strategic Collaboration and First Offering to Deliver One-of-a-Kind Enzymes for Biocatalysis
Contacts For bitBiome: info@bitbiome.bio For Twist: For Investors: Angela Bitting SVP, Corporate Affairs 925-202-6211 abitting@twistbioscience.com For Media: Amanda Houlihan Communications...
Trimble Announces Second Quarter 2024 Results
WESTMINSTER, Colo., Aug. 6, 2024 /PRNewswire/ -- Trimble Inc. (NASDAQ: TRMB) today announced financial results for the second quarter of 2024....
Trinity Capital Inc. Expands its Credit Facility with KeyBank
Credit facility can accordion to $690 million Maturity Date Extended to July 2029 PHOENIX, Aug. 5, 2024 /PRNewswire/ -- Trinity...
Tuniu Announces Unaudited Second Quarter 2024 Financial Results
NANJING, China, Aug. 6, 2024 /PRNewswire/ -- Tuniu Corporation (NASDAQ: TOUR) ("Tuniu" or the "Company"), a leading online leisure travel...
Millicom’s (Tigo) Independent Committee Reviewing Revised Tender Offers from Atlas Luxco S.à r.l
Millicom’s (Tigo) Independent Committee Reviewing Revised Tender Offers from Atlas Luxco S.à r.lLuxembourg, August 06, 2024 – On August 2,...
TG Therapeutics Reports Second Quarter 2024 Financial Results and Raises BRIUMVI® (ublituximab-xiiy) Full Year Revenue Guidance
Second quarter 2024 U.S. BRIUMVI net revenue of $72.6 millionRaising full year 2024 U.S. BRIUMVI net revenue target to approximately...
Tenax Therapeutics Announces Oversubscribed $100 Million Private Placement
CHAPEL HILL, N.C., Aug. 06, 2024 (GLOBE NEWSWIRE) -- Tenax Therapeutics, Inc. (Nasdaq: TENX) (the “Company” or “Tenax Therapeutics”), a...
Texas Capital Announces Private Credit Strategy
Tim Laczkowski Appointed to Lead Texas Capital’s Inaugural Direct Lending FundDALLAS, Aug. 05, 2024 (GLOBE NEWSWIRE) -- Texas Capital Bancshares,...
Talkspace Announces New In-Network Agreement with Humana Military (TRICARE East)
More than 6 million active-duty & retired military personnel, along with partners and dependents, will now have access to Talkspace’s...
Stagwell (STGW) Furthers MENA Expansion with Agreement to Acquire Consulum, a Leading Pan-MENA Government Advisory Consultancy
NEW YORK and RIYADH, Saudi Arabia, Aug. 6, 2024 /PRNewswire/ -- Stagwell (NASDAQ: STGW), the challenger network built to transform...
SunPower Announces Stalking Horse Asset Purchase Agreement with Complete Solaria to Sell Blue Raven Solar, New Homes, and its Non-Installing Dealer Network
Files voluntary Chapter 11 petitions to effectuate the proposed transaction Intends to operate Blue Raven Solar and New Homes through...
Rockford Mutual Insurance Company Selects Sapiens ReinsurancePro to Enhance Efficiency and Mitigate Claims Leakage
Sapiens' automation of the reinsurer's processes ensures financial stability and operational excellence ROCHELLE PARK, N.J., Aug. 6, 2024 /PRNewswire/ --...
Sacks Parente Golf, Inc. Reports Second Quarter 2024 Financial Results and Provides Corporate Update
Camarillo, Calif., Aug. 05, 2024 (GLOBE NEWSWIRE) -- Sacks Parente Golf, Inc. (NASDAQ: SPGC), (the “Company” or “Sacks Parente”), a...
SOPHiA GENETICS Reports Second Quarter 2024 Results
Strength in U.S. Growth Offset by Challenges in BioPharma and EMEA; Strong Cost Management Buffers Loss BOSTON and ROLLE, Switzerland,...
Senti Bio Announces Execution of Grant Award from California Institute for Regenerative Medicines (CIRM) for Clinical Development of SENTI-202
SOUTH SAN FRANCISCO, Calif., Aug. 05, 2024 (GLOBE NEWSWIRE) -- Senti Biosciences, Inc. (Nasdaq: SNTI) (“Senti Bio”), a biotechnology company...
Summit Therapeutics Reports Financial Results and Operational Progress for the Second Quarter and Six Months Ended June 30, 2024
Ivonescimab Monotherapy Achieved Statistically Significant & Clinically Meaningful Improvement over Pembrolizumab Monotherapy Head-to-Head in HARMONi-2 Phase III Trial in 1L...